CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- 4 Planned sale General Counsel sold 56,894 shares at an average $209.24 ($11,904,247)
- 4 Planned sale See Remarks sold 86,000 shares at an average $209.20 ($17,991,107)
- 4 Planned sale Director sold 5,580 shares at an average $187.99 ($1,048,967)
- 4 Planned sale Chief Financial Officer sold 20,000 shares at an average $168.33 ($3,366,604)
- 4 Grant or award Director acquired 1,191 shares (grant or award)
- 4 Grant or award Director acquired 1,191 shares (grant or award)
- 4 Grant or award Director acquired 1,191 shares (grant or award)
- 4 Grant or award Director acquired 1,191 shares (grant or award)
- 4 Grant or award Director acquired 1,191 shares (grant or award)
- 4 Grant or award Director acquired 1,191 shares (grant or award)
- 4 Grant or award Director acquired 1,191 shares (grant or award)
- 4 Open-market sale See Remarks sold 4,615 shares at $156.12 ($720,490)
- 4 Planned sale See Remarks sold 10,020 shares at $156.12 ($1,564,310)
- 4 Planned sale General Counsel sold 2,157 shares at $156.12 ($336,749)
- 4 Planned sale Chief Financial Officer sold 2,722 shares at $156.12 ($424,956)
- 4 Planned sale See Remarks sold 4,175 shares at $156.12 ($651,798)
- 4 Planned sale Chief Operating Officer sold 93,575 shares at an average $160.00 ($14,972,110)
- 4 Planned sale Chief Operating Officer sold 10,000 shares at an average $148.01 ($1,480,139)
- 4 Planned sale See Remarks sold 3,121 shares at an average $153.99 ($480,611)
- 4 Planned sale See Remarks sold 3,120 shares at an average $132.41 ($413,129)
Page 2 of 21 · 412 filings